Marketing-authorisation holder · Spain
Neuraxpharm Pharmaceuticals S.L.
79 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
79 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 79
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALERTEC100 mg · Tablet | Modafinil | Canada | Marketed | 1999 |
| Briumvi | Ublituximab | EU (EMA) | Authorised | 2023 |
| BRIUMVIConcentrato per soluzione per infusione | Ublituximab | Italy | Authorised | |
| Briumvi 150 mg concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie | Ublituximab | Netherlands | Authorised | 2023 |
| BRIUMVI 150 MG CONCENTRADO PARA SOLUCION PARA PERFUSION150 mg · Concentrado para solución para perfusión | Ublituximab | Spain | Marketed | 2023 |
| BUCCOLAM10 mg / 2 ml · Solution | Midazolam | Canada | Marketed | 2026 |
| BUCCOLAMSoluzione per mucosa orale | Midazolam | Italy | Authorised | |
| BUCCOLAM7.5 mg / 1.5 ml · Solution | Midazolam | Canada | Marketed | 2026 |
| BUCCOLAM5 mg / 1 ml · Solution | Midazolam | Canada | Marketed | 2026 |
| Buccolam | Midazolam | EU (EMA) | Authorised | 2011 |
| BUCCOLAM2.5 mg / 0.5 ml · Solution | Midazolam | Canada | Marketed | 2026 |
| BUCCOLAM 10 MG SOLUCION BUCAL5,00 mg · Solución bucal | Midazolam | Spain | Marketed | 2012 |
| BUCCOLAM 2,5 MG SOLUCION BUCAL5,00 mg · Solución bucal | Midazolam | Spain | Marketed | 2012 |
| BUCCOLAM 5 MG SOLUCION BUCAL5,00 mg · Solución bucal | Midazolam | Spain | Marketed | 2012 |
| BUCCOLAM 7,5 MG SOLUCION BUCAL5,00 mg · Solución bucal | Midazolam | Spain | Marketed | 2012 |
| BUPRENORFINA NEURAXPHARMFilm sublinguale | Buprenorphine | Italy | Authorised | |
| Buprenorfine Neuraxpharm 0,4 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine | Netherlands | Authorised | 2024 |
| Buprenorfine Neuraxpharm 4 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine | Netherlands | Authorised | 2024 |
| Buprenorfine Neuraxpharm 6 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine | Netherlands | Authorised | 2024 |
| Buprenorfine Neuraxpharm 8 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine | Netherlands | Authorised | 2024 |
| Buprenorphine Neuraxpharm | Buprenorphine | EU (EMA) | Authorised | 2024 |
| Dimethyl fumarate Neuraxpharm | Dimethyl | EU (EMA) | Authorised | 2024 |
| Dimethylfumaraat Neuraxpharm 120 mg maagsapresistente harde capsulesMaagsapresistente capsule, hard | Dimethyl | Netherlands | Authorised | 2024 |
| Dimethylfumaraat Neuraxpharm 240 mg maagsapresistente harde capsulesMaagsapresistente capsule, hard | Dimethyl | Netherlands | Authorised | 2024 |
| DIMETILFUMARATO NEURAXPHARMCapsula rigida gastroresistente | Dimethyl | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 30 | 27 | 3 | CompaniesAll medicines |
| Netherlands | 26 | 26 | 0 | CompaniesAll medicines |
| European Union (EMA) | 9 | 8 | 1 | CompaniesAll medicines |
| Italy | 9 | 9 | 0 | CompaniesAll medicines |
| Canada | 5 | 5 | 0 | CompaniesAll medicines |
Also in the registers of Croatia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.